$38.75
-1.10-2.76%
At close: -
$38.87
0.120.31%
After Hours: 7:59 PM EDT
Comments
Loading...
GSK Stock Guidance | NYSE:GSK | Benzinga
GSK issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | GSK | GSK | FY | 2025 | $4.25 | $4.59 | $4.36 | $40.68B | $42.71B | $32.61B | Get Alert |
| 02/05/2025 | GSK | GSK | FY | 2025 | $4.18 | $4.26 | $4.52 | $40.07B | $40.85B | $34.29B | Get Alert |
| 10/30/2024 | GSK | GSK | FY | 2024 | $1.71 | $1.74 | $4.06 | $40.94B | $41.71B | $41.46B | Get Alert |
| 07/31/2024 | GSK | GSK | FY | 2024 | $1.71 | $1.74 | $4.04 | $40.94B | $41.71B | $40.67B | Get Alert |
| 05/01/2024 | GSK | GSK | FY | 2024 | $2.12 | $2.16 | $3.96 | $41.16B | $41.16B | $39.57B | Get Alert |
| 01/31/2024 | GSK | GSK | FY | 2024 | $1.64 | $1.69 | $4.05 | $39.53B | $40.29B | $39.82B | Get Alert |
| 11/01/2023 | GSK | GSK | FY | 2023 | $2.07 | $2.12 | $3.86 | $41.58B | $41.95B | $35.50B | Get Alert |
| 07/26/2023 | GSK | GSK | FY | 2023 | $1.99 | $2.05 | $3.80 | $39.63B | $40.37B | $37.43B | Get Alert |
| 04/26/2023 | GSK | GSK | FY | 2023 | $1.90 | $1.96 | $3.68 | $37.75B | $38.47B | $35.72B | Get Alert |
| 02/01/2023 | GSK | GSK | FY | 2023 | $1.94 | $1.99 | $3.64 | $38.54B | $39.27B | $35.92B | Get Alert |
| 11/02/2022 | GSK | GSK | FY | 2022 | — | — | — | $50.67B | $51.60B | $32.29B | Get Alert |
| 07/27/2022 | GSK | GSK | FY | 2022 | — | — | — | $49.73B | $50.67B | $38.72B | Get Alert |
| 10/27/2021 | GSK | GlaxoSmithKline | FY | 2021 | $1.56 | $1.59 | $2.86 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for GSK (GSK)?
The most recent guidance for GSK (GSK) was reported on April 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $4.25 to $4.59, compared to the estimated EPS of $4.36. Additionally, GSK forecasted revenue between $40.68B and $42.71B for the quarter.
Browse guidance and forecast on all stocks.
